Clinical Trials Logo
  1. Home
  2. Laryngeal Cancer
  3. NCT05349487

SpeakFree Heat and Moisture Exchanger (HME) — SPEAKFREE  

Laryngeal Cancer Clinical Trial

Official title:
Evaluation of a Disposable Hands-Free Heat and Moisture Exchanger (HME) Valve: The Blom-Singer SpeakFree HME Hands Free Valve

Clinical Trial Summary

The purpose of the study is to evaluate the new Blom-Singer SpeakFree disposable hands free valve heat and moisture exchanger (HME). The investigators will compare the SpeakFree to other modalities of stomal occlusion (digital occlusion and digital depression of an HME) for patients who communicate with a voice prosthesis as determined by patient preference and satisfaction. In addition, the investigators will compare the SpeakFree to other modalities of stomal occlusion as determined by objective measures of speech and voice parameters (maximum phonation time, syllables per breath, minimum/maximum phonation pressures, and a clinician rating of voice quality using a visual analog scale).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05349487
Study type Interventional
Source University of Miami
Contact Jerri Halgowich
Phone 305-243-3818
Email jhalgowich@med.miami.edu
Status Recruiting
Phase N/A
Start date June 28, 2022
Completion date June 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT01089803 - Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer N/A
Completed NCT00026975 - Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients Phase 2
Completed NCT01435252 - A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab Phase 2
Recruiting NCT04174950 - Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients N/A
Recruiting NCT05857202 - Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer
Recruiting NCT06077643 - Workshops and Exchange Groups for Laryngectomized Patients
Not yet recruiting NCT06137378 - European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] Phase 2
Active, not recruiting NCT02586207 - Pembrolizumab in Combination With CRT for LA-SCCHN Phase 1
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research
Recruiting NCT05375266 - Immune Biomarker Study for Head and Neck Cancer
Completed NCT03134976 - Wound Complications in Head and Neck Surgery
Recruiting NCT04650919 - Aortic Laryngeal Rehabilitation Graft N/A
Recruiting NCT05830240 - A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer Early Phase 1
Terminated NCT02437513 - NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration N/A
Completed NCT01633541 - Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer Phase 2
Completed NCT01332682 - Resistance Training and Physical Functioning in Head and Neck Cancer Patients Phase 1
Terminated NCT00011492 - Patient Evaluation for Head and Neck Surgery Branch Studies
Completed NCT00467948 - Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients Phase 3
Recruiting NCT06024980 - Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy N/A
Recruiting NCT03747783 - Nomograms to Precisely Predict Conditional Risk of Survival for Patients With Laryngeal Cancer